Neuphoria Therapeutics Inc. Balance Sheet
NEUP|1 years of annual SEC 10-K data (FY2025-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity. All figures from audited SEC 10-K filings.
Neuphoria Therapeutics Inc. had $29M in total assets and $19M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.76 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 |
|---|---|
| Cash & Equivalents | $14.2M |
| Accounts Receivable | $11.9K |
| Current Assets | $15.0M |
| PP&E (Net) | $2.8K |
| Goodwill | $8.6M |
| Total Assets | $28.6M |
| Current Liabilities | $4.2M |
| Shareholders' Equity | $19.0M |